ClassID:

109766

C12N2710/16034 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260007739
2026-01-08

HERPESVIRUS COMPOSITIONS AND RELATED METHODS

#2
20250295753
2025-09-25

Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens

#3
20250213676
2025-07-03

REPLICATION-COMPETENT CONTROLLED ALPHA-HERPESVIRUS VECTORS AND USES THEREFORE

#4
20250163108
2025-05-22

SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS

#5
20250152700
2025-05-15

ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE

#6
20240374702
2024-11-14

RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#7
20240374509
2024-11-14

VIRUS

#8
20240270796
2024-08-15

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

#9
20240189353
2024-06-13

MODULATED IMMUNODOMINANCE THERAPY

#10
20240148855
2024-05-09

CANCER VACCINE AND METHOD OF USE THEREOF

#11
20230372474
2023-11-23

RECOMBINANT HVT AND USES THEREOF

#12
20230293674
2023-09-21

HSV-2-delta-gD vaccines and methods for their production and use

#13
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

#14
20230031097
2023-02-02

MULTIVALENT HVT VECTOR VACCINE

#15
20220409718
2022-12-29

Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

#16
20220340884
2022-10-27

VACCINES FOR TREATING SARS INFECTIONS IN CANCER PATIENTS

#17
20220193230
2022-06-23

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

#18
20220133881
2022-05-05

Herpesvirus compositions and related methods

#19
20220105173
2022-04-07

VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM

#20
20220008534
2022-01-13

Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer

#21
20210386854
2021-12-16

Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same

#22
20210290758
2021-09-23

Epstein-Barr virus-like particles with broadened antigenic spectrum

#23
20210236625
2021-08-05

HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE

#24
20210196811
2021-07-01

Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

#25
20210163542
2021-06-03

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

#26
20200368346
2020-11-26

Liquid vaccines of live enveloped viruses

#27
20200306298
2020-10-01

Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

#28
20200263147
2020-08-20

Non-neuroinvasive viruses and uses thereof

#29
20200263146
2020-08-20

Non-neuroinvasive viruses and uses thereof

#30
20200138942
2020-05-07

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#31
20200069795
2020-03-05

Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye

#32
20200038501
2020-02-06

Immunization agents and methods of use

#33
20200017554
2020-01-16

SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS

#34
20190367561
2019-12-05

Vaccine compositions of herpesvirus envelope protein combinations to induce immune response

#35
20190350846
2019-11-21

Virus

#36
20190284259
2019-09-19

Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides

#37
20190211313
2019-07-11

Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors

#38
20190031723
2019-01-31

Truncated glycoprotein G of herpes simplex virus 2

#39
20180371026
2018-12-27

Feline calicivirus vaccine

#40
20180333485
2018-11-22

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

#41
20180171309
2018-06-21

Immortalised chicken embryo fibroblasts

#42
20180162912
2018-06-14

Cytokine

#43
20180085313
2018-03-29

Thermostable vaccines based on ether lipids and native viral envelope proteins

#44
20180080047
2018-03-22

Promoters

#45
20180055926
2018-03-01

Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#46
20180044643
2018-02-15

Non-neuroinvasive viruses and uses thereof

#47
20170342442
2017-11-30

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

#48
20170340722
2017-11-30

Immunization agents and methods of use

#49
20170281754
2017-10-05

Compositions and methods for enhanced innate immunity

#50
20170232096
2017-08-17

Vaccine in the form of a recombinant sero type 9 avian adenovirus vector

#51
20170224808
2017-08-10

THERAPEUTIC COMPOSITIOJNS AND METHODS FOR INDUCING AN IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS TYPE 2 (HSV-2)

#52
20170216357
2017-08-03

Modulated immunodominance therapy

#53
20170072046
2017-03-16

Immunogenic composition

#54
20170049880
2017-02-23

Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector

#55
20170049877
2017-02-23

West Nile Virus vaccine

#56
20170042998
2017-02-16

MODULATED IMMUNODOMINANCE THERAPY

#57
20170028058
2017-02-02

HERPES SIMPLEX VIRUS VACCINES

#58
20170028057
2017-02-02

Koi herpesvirus vaccine

#59
20170028042
2017-02-02

T cell expansion

#60
20160263211
2016-09-15

Stimulation of neonatal immunity against EHV-1

#61
20160263210
2016-09-15

Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof

#62
20160235840
2016-08-18

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

#63
20160017284
2016-01-21

Cyprinid herpesvirus II-sensitive brain tissue cell line of and establishing method and use thereof

#64
20160008458
2016-01-14

Conditionally replication deficient herpes virus and use thereof in vaccines

#65
20160008449
2016-01-14

CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE

#66
20150290318
2015-10-15

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

#67
20150290165
2015-10-15

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#68
20150190502
2015-07-09

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

#69
20150152141
2015-06-04

Cytokine

#70
20150150964
2015-06-04

Herpesvirus compositions and related methods

#71
20150147354
2015-05-28

Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

#72
20150004188
2015-01-01

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

#73
20140363466
2014-12-11

METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS

#74
20140348875
2014-11-27

KOI HERPESVIRUS VACCINE

#75
20140328870
2014-11-06

Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

#76
20140314811
2014-10-23

Herpes simplex virus vaccines

#77
20130337000
2013-12-19

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

#78
20130309262
2013-11-21

HSV-1 epitopes and methods for using same

#79
20130004547
2013-01-03

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

#80
20120263752
2012-10-18

Herpes simplex virus vaccines

#81
20120263677
2012-10-18

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#82
20120171230
2012-07-05

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

#83
20110287050
2011-11-24

RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI

#84
20110159033
2011-06-30

West Nile Virus vaccine

#85
20110098212
2011-04-28

Cytokine

#86
20100203073
2010-08-12

HSV-1 epitopes and methods for using same

#87
20100178301
2010-07-15

Method of treating pregnant cows and/or heifers

#88
20090191239
2009-07-30

Recombinant infectious laryngotracheitis virus and uses thereof

#89
20090176203
2009-07-09

Mutant HSV, materials and methods for generation of mutant HSV

#90
20090060951
2009-03-05

DNA vaccine for Koi herpes virus (KHV) disease

#91
20080175859
2008-07-24

Recombinant infectious laryngotracheitis virus and uses thereof

#92
20070280964
2007-12-06

Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

#93
20070212377
2007-09-13

Recombinant herpesvirus and uses thereof

#94
20070196390
2007-08-23

Equine herpesvirus vaccine

#95
20070098744
2007-05-03

Probiotic enterococci for improved immunity

#96
20070031450
2007-02-08

Stabilizers for veterinary vaccines

#97
20060216311
2006-09-28

Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA

#98
20060140976
2006-06-29

Trivalent vaccine with maternal anitbody transfer via the milk

#99
20060111558
2006-05-25

Recombinant infectious laryngotracheitis virus and uses thereof

#100
20060013828
2006-01-19

Immunizing fish against viral infection

#101
20050084502
2005-04-21

Equine herpesvirus vaccine